We are live on
!
Find out more
E Fund Management Portfolio holdings
AUM
$4.46B
Turnover
13.19%
This Fund
S&P 500
This Quarter
Est. Return
+11.44%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.81B
AUM Growth
+$194M
(+12%)
Cap. Flow
+$40.5M
Cap. Flow
% of AUM
2.24%
Top 10 Holdings %
Top 10 Hldgs %
63.7%
Holding
392
New
24
Increased
176
Reduced
102
Closed
74
Avg Time Held
2.1
years
Top 10 Avg Time Held
1.1
years
Top 20 Avg Time Held
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Futu Holdings
FUTU
|
+$32.5M |
| 2 |
Applied Materials
AMAT
|
+$26.5M |
| 3 |
Apple
AAPL
|
+$13.7M |
| 4 |
Microsoft
MSFT
|
+$11.9M |
| 5 |
NVIDIA
NVDA
|
+$9.49M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$28.3M |
| 2 |
KE Holdings
BEKE
|
+$13.2M |
| 3 |
TSMC
TSM
|
+$13.2M |
| 4 |
ASE Group
ASX
|
+$7.59M |
| 5 |
iQIYI
IQ
|
+$6.13M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 39.73% |
| 2 | Technology | 31.74% |
| 3 | Communication Services | 9.52% |
| 4 | Healthcare | 5.08% |
| 5 | Financials | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
NXP Semiconductors
NXPI
$58.8B
| $1.39M | 0.08% |
5,155
+865
| +20% | +$223K |
2021 Q1
13 quarters
|
|
102
Sarepta Therapeutics
SRPT
$1.83B
| $1.38M | 0.08% |
8,761
+5,276
| +151% | +$678K |
2022 Q1
9 quarters
|
|
103
Booking.com
BKNG
$125B
| $1.35M | 0.07% |
8,500
+50
| +0.6% | +$7.41K |
2021 Q1
13 quarters
|
|
104
O'Reilly Automotive
ORLY
$72.5B
| $1.33M | 0.07% |
18,855
+10,110
| +116% | +$699K |
2021 Q1
13 quarters
|
|
105
Cullinan Oncology
CGEM
$862M
| $1.3M | 0.07% |
+74,827
| New | +$1.59M |
2024 Q2
0 quarters
|
|
106
Wells Fargo
WFC
$252B
| $1.3M | 0.07% |
21,947
+1,944
| +10% | +$115K |
2021 Q1
13 quarters
|
|
107
Abbott
ABT
$181B
| $1.3M | 0.07% |
12,487
+1,413
| +13% | +$150K |
2021 Q1
13 quarters
|
|
108
United Therapeutics
UTHR
$23B
| $1.24M | 0.07% |
3,908
+2,125
| +119% | +$562K |
2022 Q1
9 quarters
|
|
109
Royal Caribbean
RCL
$76.2B
| $1.23M | 0.07% |
7,700
| – | – |
2023 Q4
2 quarters
|
|
110
Incyte
INCY
$23B
| $1.23M | 0.07% |
20,240
+9,733
| +93% | +$551K |
2021 Q1
13 quarters
|
|
111
Roper Technologies
ROP
$37.7B
| $1.22M | 0.07% |
2,158
+370
| +21% | +$199K |
2022 Q2
8 quarters
|
|
112
Alnylam Pharmaceuticals
ALNY
$31.4B
| $1.2M | 0.07% |
4,926
+2,112
| +75% | +$333K |
2022 Q1
9 quarters
|
|
113
Fate Therapeutics
FATE
$223M
| $1.17M | 0.06% |
355,225
+320,745
| +930% | +$1.4M |
2024 Q1
1 quarter
|
|
114
Pfizer
PFE
$169B
| $1.16M | 0.06% |
41,469
+3,683
| +10% | +$101K |
2021 Q1
13 quarters
|
|
115
McDonald's
MCD
$172B
| $1.14M | 0.06% |
4,483
+476
| +12% | +$126K |
2021 Q1
13 quarters
|
|
116
DELISTED
Exact Sciences
EXAS
| $1.14M | 0.06% |
26,879
+19,661
| +272% | +$1.08M |
2022 Q1
9 quarters
|
|
117
Walt Disney
DIS
$193B
| $1.13M | 0.06% |
11,395
+1,267
| +13% | +$136K |
2021 Q1
13 quarters
|
|
118
BioMarin Pharmaceuticals
BMRN
$10.7B
| $1.11M | 0.06% |
13,480
+8,438
| +167% | +$702K |
2022 Q1
9 quarters
|
|
119
Verizon
VZ
$186B
| $1.08M | 0.06% |
26,212
+2,997
| +13% | +$121K |
2021 Q1
13 quarters
|
|
120
Natera
NTRA
$56.1B
| $1.08M | 0.06% |
9,979
+5,113
| +105% | +$519K |
2022 Q1
9 quarters
|
|
121
Viking Therapeutics
VKTX
$3.33B
| $1.08M | 0.06% |
20,380
+14,342
| +238% | +$940K |
2023 Q1
5 quarters
|
|
122
Autodesk
ADSK
$50.1B
| $1.07M | 0.06% |
4,323
+758
| +21% | +$170K |
2021 Q1
13 quarters
|
|
123
Nike
NKE
$55.7B
| $1.06M | 0.06% |
14,084
| – | – |
2021 Q1
13 quarters
|
|
124
Caterpillar
CAT
$340B
| $1.03M | 0.06% |
3,091
+2,321
| +301% | +$805K |
2022 Q4
6 quarters
|
|
125
ICICI Bank
IBN
$108B
| $1.03M | 0.06% |
35,624
+13,905
| +64% | +$373K |
2024 Q1
1 quarter
|
|
Similar funds
E Fund Management's Q2 2024 Portfolio in Review
As of Q2 2024, E Fund Management held 392 positions worth $1.81B, up 12% from $1.61B the previous quarter. Its ten largest holdings account for 64% of the portfolio.
E Fund Management's Q2 2024 filing shows 24 new, 176 increased, 102 reduced and 74 closed positions. Its largest new stake was Futu Holdings: 480,000 shares worth $31.5M. The largest sale was Advanced Micro Devices, an estimated $28.3M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 40% of assets, down from 40% a quarter earlier, followed by Technology and Communication Services.
- E Fund Management's largest Q2 2024 buy was Futu Holdings: 480,000 shares worth $31.5M.
- E Fund Management added most to Applied Materials in Q2 2024, an estimated $26.5M increase.
- E Fund Management's biggest Q2 2024 reduction was Advanced Micro Devices, cutting an estimated $28.3M.
- E Fund Management fully exited Yum China in Q2 2024, selling an estimated $5.17M.
- E Fund Management's ten largest holdings make up 64% of its $1.81B portfolio in Q2 2024.
- E Fund Management opened 24 new positions and closed 74 in Q2 2024.
- E Fund Management's portfolio value rose 12% quarter-over-quarter to $1.81B.
Based on E Fund Management's 13F filing for Q2 2024, filed 12 Aug 2024.